Within-person consistency of acute treatment success with ubrogepant: Results from a long-term safety study

被引：0
|
作者：
Iaconangelo, C. [1 ]
Serrano, D. [2 ]
Engstrom, E. [2 ]
Contreras-De Lama, J. [3 ]
Trugman, J. M. [4 ]
Adams, Manack A. [5 ]
Lipton, R. B. [6 ]
机构：
[1] OPEN Hlth, New York, NY USA
[2] OPEN Hlth, Bethesda, MD USA
[3] AbbVie Inc, Irvine, CA USA
[4] AbbVie, Madison, NJ USA
[5] AbbVie, Irvine, CA USA
[6] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
HEADACHE | 2022年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-208
引用
收藏
页码：169 / 170
页数：2
相关论文
共 50 条
  • [31] Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study
    Ailani, Jessica
    Lipton, Richard B.
    Blumenfeld, Andrew M.
    Mechtler, Laszlo
    Klein, Brad C.
    He, Molly Yizeng
    Smith, Jonathan H.
    Trugman, Joel M.
    Ferreira, Rosa de Abreu
    Brand-Schieber, Elimor
    HEADACHE, 2024,
  • [32] Long-Term Tanezumab Treatment for Osteoarthritis: Efficacy and Safety Results
    Bello, Alfonso E.
    Ekman, Evan F.
    Radin, David
    Davignon, Isabelle
    Smith, Michael D.
    Brown, Mark T.
    West, Christine R.
    Verburg, Kenneth M.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S112 - S113
  • [33] What is the long-term prognosis of acute myocarditis? Results of a long-term prospective study
    Martins, A.
    Vilela, M.
    Oliveira, C.
    Garcia, A. B.
    Abrantes, A.
    Raposo, M.
    Ferreira, D.
    Nobre De Menezes, M.
    Silva Marques, J.
    Valente Silva, B.
    Rigueira, J.
    Placido, R.
    Brito, D.
    Almeida, A. G.
    Pinto, F. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 507 - 507
  • [34] Efficacy, Safety, and Tolerability of Ubrogepant for the Acute Treatment of Migraine: Results from a Single Attack Phase III Study, ACHIEVE II
    Lipton, R. B.
    Dodick, D. W.
    Ailani, J.
    Lu, K.
    Lakkis, H.
    Finnegan, M.
    Szegedi, A.
    Trugman, J. M.
    HEADACHE, 2018, 58 (08): : 1315 - 1316
  • [35] Anakinra safety experience: Infection results from a long-term safety study and postmarketing experience
    Veith, J
    Wallis, WJ
    Modafferi, D
    Viveash, D
    Bakker, P
    Solinger, A
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 191 - 191
  • [36] LONG-TERM SAFETY AND EFFICACY WITH FIBREL IN THE TREATMENT OF CUTANEOUS SCARS - RESULTS OF A MULTICENTER STUDY
    MILLIKAN, L
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1989, 15 (08): : 837 - 842
  • [37] Long-Term Safety of Rimegepant 75 mg for the Acute Treatment of Migraine (Study 201)
    Croop, Robert
    Berman, Gary
    Kudrow, David
    Mullin, Kathleen
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charles
    Jensen, Christopher
    Lovegren, Meghan
    Coric, Vladimir
    Lipton, Richard
    NEUROLOGY, 2020, 94 (15)
  • [38] Long-Term Safety of Rimegepant 75 Mg for the Acute Treatment of Migraine (Study 201)
    Croop, R.
    Berman, G.
    Kudrow, D.
    Mullin, K.
    Stock, E. G.
    Thiry, A. C.
    Conway, C. M.
    Jensen, C. M.
    Lovegren, M.
    Coric, V
    Lipton, R. B.
    HEADACHE, 2020, 60 : 111 - 112
  • [39] Acute DVT: Long-term results of conservative treatment - Discussion
    Kaplan
    Strandness
    Partsch
    Hull
    Rutherford
    Royle
    Nicolaides
    VASCULAR SURGERY, 1997, 31 (03): : 310 - 311
  • [40] Long-term results of nonoperative treatment for uncomplicated acute appendicitis
    Kirkil, Cuneyt
    Yigit, Mehmet Volkan
    Aygen, Erhan
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (04): : 393 - 397
12345